Core Viewpoint - Via Transportation, Inc. has announced the pricing of its initial public offering (IPO) at $46.00 per share, indicating strong market interest in its public transit technology solutions [1] Summary by Category IPO Details - The company is offering a total of 10,714,285 shares of its Class A common stock, with 7,142,857 shares being offered by Via and 3,571,428 shares by selling stockholders [1] - The underwriters have been granted a 30-day option to purchase additional shares, which could indicate confidence in the demand for the offering [1]

Group 1 - Gemini Space Station, Inc. announced the pricing of its initial public offering (IPO) of 15,178,572 shares of Class A common stock at a price of $28.00 per share [1] - The offering includes a 30-day option for underwriters to purchase an additional 300,565 and 458,364 shares of Class A common stock to cover over-allotments [1] - Trading of Gemini's Class A common stock is expected to begin on the Nasdaq Global Select Market under the ticker symbol "GEMI" on September 12, 2025, with the offering closing on September 15, 2025, subject to customary closing conditions [1] Group 2 - Goldman Sachs & Co. LLC and Citigroup are acting as lead bookrunners for the IPO, with Morgan Stanley and Cantor also participating as lead bookrunners [2] - Additional bookrunners include Evercore ISI, Mizuho, Truist Securities, Cohen & Company Capital Markets, Keefe, Bruyette & Woods, A Stifel Company, Needham & Company, and Rosenblatt [2] Group 3 - The offering is being made only by means of a prospectus, which can be obtained from the SEC's website or directly from Goldman Sachs and Citigroup [3] - A registration statement for these securities has been filed with and declared effective by the SEC [4] Group 4 - Gemini is a global crypto platform founded in 2014 by Cameron and Tyler Winklevoss, offering a wide range of crypto products and services in over 60 countries [5]

SAN JOSE, Calif.--(BUSINESS WIRE)--Legence Corp. ("Legence†) announced today the pricing of its initial public offering (the "offering†) of 26,000,000 shares of its Class A common stock (the "Common Stock†) at a price to the public of $28.00 per share. The underwriters of the offering were granted a 30-day option to purchase up to an additional 3,900,000 shares of Common Stock at the initial public offering price, less underwriting discounts and commissions. The Common Stock is expected to begi. ...

Core Insights - Gemini Space Station raised $425 million in an initial public offering (IPO) [1] - The stock was priced above the marketed range, indicating strong demand [1] - The number of shares offered was reduced, which may reflect a strategic decision to enhance stock value [1] Financial Summary - The total amount raised in the IPO was $425 million [1] - The pricing strategy involved setting the stock price above the initially marketed range, suggesting positive market sentiment [1] - The reduction in the number of shares offered could imply a focus on maintaining a higher stock price post-IPO [1]

Gemini raised $425 million in an initial public offering, pricing its stock above a marketed range and shrinking the number of shares, according to a person familiar with the matter https://t.co/dAfdvXCuwW ...

Core Points - Trailblazer Acquisition Corp. successfully closed its upsized initial public offering (IPO) of 27,500,000 units, generating gross proceeds of $275,000,000 at a price of $10.00 per unit [1][3] - The units began trading on Nasdaq under the ticker symbol "BLZRU" on September 10, 2025, with each unit comprising one Class A ordinary share and one-third of a redeemable warrant [2] - The company is a blank check entity aiming to pursue mergers or acquisitions primarily in the media and communications, sports and entertainment, technology, and consumer retail sectors [4] Financial Details - The IPO included a partial exercise of the underwriters' over-allotment option, resulting in the issuance of an additional 3,500,000 units [1] - A total of $275,000,000 from the IPO proceeds was placed in a trust account for the company [3] Management and Structure - The management team is led by CEO Eric Semler and CFO Eamon P. Smith, with a board that includes Thomas J. Lee, Thomas S. ("Tad") Smith, Jr., and Steven Silverstein [5] - Cantor Fitzgerald & Co. served as the sole book-running manager for the offering [5]

Gemini is telling investors it expects to cap the base size of its initial public offering at $425 million ahead of pricing later on Thursday, according to sources https://t.co/Ro98IZJehp ...

The window for initial public offerings in Europe has opened in earnest this week, with a flurry of listings indicating the tariff-induced caution that disrupted deals earlier in the year has passed https://t.co/CqPHOkk5OY ...

Company Overview - LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for schizophrenia, bipolar depression, and other neuropsychiatric diseases [5] - The company is advancing its lead product candidate, LB-102, which aims to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States [5] - LB-102 is positioned to potentially become a mainstay in psychiatric practice, offering an alternative to existing branded and generic therapeutics [5] Initial Public Offering (IPO) Details - LB Pharmaceuticals announced the pricing of its upsized initial public offering of 19,000,000 shares at a public offering price of $15.00 per share, expecting gross proceeds of $285.0 million before expenses [1] - The offering includes a 30-day option for underwriters to purchase an additional 2,850,000 shares at the initial public offering price [1] - Shares are set to begin trading on the Nasdaq Global Market under the ticker symbol "LBRX" on September 11, 2025, with the offering expected to close on September 12, 2025 [2] Regulatory and Compliance Information - A registration statement on Form S-1 has been filed with the U.S. Securities and Exchange Commission (SEC) and became effective on September 10, 2025 [3] - The offering is being conducted only through a written prospectus, with copies available from the joint bookrunning managers [3]

Core Points - Talon Capital Corp. successfully closed its initial public offering (IPO) of 24,900,000 units at a price of $10.00 per unit, raising total gross proceeds of $249,000,000 before expenses on September 10, 2025 [1] - The units began trading on Nasdaq under the ticker symbol "TLNCU" on September 9, 2025, with each unit consisting of one Class A ordinary share and one-third of a redeemable public warrant [2] - Cohen & Company Capital Markets served as the lead book-running manager for the public offering [3] Additional Information - A registration statement for the securities became effective on September 8, 2025 [4] - The press release includes forward-looking statements regarding the anticipated use of net proceeds from the offering [5] - Contact information for Talon Capital Corp. is provided for further inquiries [6]